Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New safety bundle aims to slash maternal sepsis deaths

NCT ID NCT06145724

First seen Jan 23, 2026 · Last updated Jun 18, 2026 · Updated 23 times

Summary

This study aims to reduce deaths from maternal sepsis, a leading cause of death in new mothers in the U.S. Researchers will create and test a safety bundle in four hospitals, involving over 33,000 birthing people. The goal is to see if the bundle helps diagnose and treat sepsis faster, saving lives.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Columbia Unviersity Irving Medical Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • NYC Health + Hospitals/Lincoln

    RECRUITING

    The Bronx, New York, 10451, United States

    Contact Email: •••••@•••••

  • NYC Health+Hospitals/Harlem

    RECRUITING

    New York, New York, 10037, United States

    Contact Email: •••••@•••••

  • NewYork-Presbyterian Allen Hospital

    RECRUITING

    New York, New York, 10034, United States

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Infections infectious disease Pregnancy Complications, Infectious

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.